M&A Update – May 1

– ISEE to be acquired by Astellas Pharma for $40.00 cash per share, 64.4% premium, $5.9 billion
– MDWT to be acquired by Antarctica Capital for $27.00 cash per share, 97.4% premium, $100 million
– LMST / PEBO deal closed
– OSH shareholders approved CVS merger
– RXDX / MRK filed PREM14a, filed HSR Apr 21, closing Q3
– KBAL / HNI filed DEFM14a, vote May 31, closing mid 2023
– HSKA / Mars filed PREM14a, filed HSR Apr 14, closing H2 2023
– BKI shareholders approved ICE merger
– MLVF / FRBA shareholders approved merger